<DOC>
	<DOCNO>NCT02514616</DOCNO>
	<brief_summary>The investigational device use trial EndoStim® Lower Esophageal Sphincter ( LES ) Stimulation System . The purpose trial evaluate safety effectiveness electrical stimulation therapy ( EST ) low esophageal sphincter ( LES ) treatment subject gastroesophageal reflux disease ( GERD ) . The study population consist subject diagnose pathological GERD define abnormal pH complain heartburn , regurgitation &gt; 6 month , daily PPI use .</brief_summary>
	<brief_title>Electrical Stimulation Therapy ( EST ) Lower Esophageal Sphincter ( GERD )</brief_title>
	<detailed_description>Study Design : Multicenter , randomize , double-blind , sham-controlled study . All subject undergo screen baseline visit , follow system implantation , randomization 2 week either treatment Group ( stimulation ) Control Group ( delay stimulation ) . Randomized subject complete 10-week , double-blind phase . At 14-week visit , subject unblinded , control group subject begin receive stimulation , subject follow additional 9-month open-label treatment phase . Subjects continue receive stimulation extend follow-up phase involve annual visit 5 year . Study Visits : Screening baseline visit . Laparoscopic implantable pulse generator ( IPG ) lead implant procedure . Post-implant follow-up office visit 2 weeks/randomization , 6 , 10 , 14 , 24 48 week , follow annual visit 5 year . Sample Size Scope : Forty-six subject implant follow 12 month stimulation treatment 3 investigational site .</detailed_description>
	<criteria>Subject able willing provide write informed consent Subject able willing comply require study procedure followup schedule Typical symptom GERD ( regurgitation and/or heartburn ) long 6 month , heartburn respond PPI therapy . Subject may also complain atypical symptom GERD may persist PPI Daily dose PPI acid neutralization drug PPI intolerance Baseline visit GERDHRQL score ≥ 20 follow 14 day offPPI least 10 point high onPPI ( acidneutralization drug ) GERDHRQL score record Screening Visit Excessive low esophageal acid exposure pH monitoring ( defined distal esophageal pH &lt; 4 &gt; 5.0 % monitoring time ) perform 14 day PPIs Subject suitable surgical candidate able undergo general anesthesia laparoscopic surgery . Previous EndoStim LES System implant and/or implant attempt Previous esophageal surgery , include Nissen fundoplication Previous endoscopic intervention treatment GERD and/or Barrett 's esophagus Hiatal hernia large 2 cm determine diagnostic investigation ( i.e. , endoscopy , manometry laparoscopic visualization ) Gastroparesis Any nonGERD esophageal motility disorder Esophageal stricture significant esophageal anatomic abnormality Barrett 's epithelium grade dysplasia Documented history esophagitis Grade C D ( LA Classification ) History suspect confirmed esophageal gastric cancer Esophageal gastric varix Symptoms dysphagia per week within last 3 month Suspected known allergy titanium , platinum , iridium , stainless steel , silicone , epoxy , nylon Body mass index ( BMI ) &gt; 35 kg/m2 Any significant multisystem diseases Autoimmune connective tissue disorder ( scleroderma , dermatomyositis , CalcinosisRaynaud'sEsophagus Sclerodactyly Syndrome ( CREST ) , Sjogren 's Syndrome , Sharp 's Syndrome , etc . ) require therapy precede 2 year Type 1 diabetes mellitus uncontrolled Type 2 diabetes mellitus ( T2DM ) define HbA1c &gt; 9.5 previous 6 month screening/baseline , T2DM &gt; 10 year Significant cardiac arrhythmia ectopy significant cardiovascular disease ( i.e . unstable angina pectoris , hemodynamically significant valvular disease , severe congestive heart failure ) , cardiac therapeutic intervention within last 6 month . Significant cerebrovascular event within last 6 month Existing implanted electrical stimulator ( pacemaker , implantable cardioverter defibrillator , deep brain stimulator ( DBS ) , bone growth pelvic floor stimulators , drug pump , etc . ) Chronic anticoagulant therapy Female subject childbearing potential pregnant nursing , intend become pregnant trial period , use reliable form birth control Subject currently enrol potentially confound research Active infection determine investigator History malignancy last 2 year Life expectancy le 3 year Diagnosed major psychiatric disorder ( bipolar , schizophrenia , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Reflux</keyword>
	<keyword>Reflux disease</keyword>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>Lower esophageal sphincter stimulation</keyword>
</DOC>